Navamedic’s OTC Sales Grow Double Digits As It Takes Eroxon To Finland

Finland is the latest market launch for OTC erectile dysfunction treatment Eroxon. High demand for the product in other countries, such as Norway, helped drive up Navamedic's consumer health sales in the first nine months of 2024.

IV1812_BC-Platforms__1200.jpg
• Source: Shutterstock

More from Earnings

More from Geography